Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivastatin versus atorvastatin around PCI in acute coronary syndrome
ChiCTR-IPR-15007035Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pitavastatin and atorvastatin in acute coronary syndrome (ACS) (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: cholesterol, triglyceride and 2 more. Started Aug 2015; status: recruiting.
02
Drugs
pitavastatinatorvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-IPR-15007035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007035.